Acacia, twice foiled by manufacturing CRLs, gets 2020 PDUFA after bringing on new API maker

30th September 2019 Uncategorised 0

Will three be the charm for biotech Acacia and its drug candidate for post-operative nausea and vomiting? With a new contract manufacturer on board following two manufacturing related denials by the FDA, the drugmaker said it has won its third action date which is set for early in 2020.

More: Acacia, twice foiled by manufacturing CRLs, gets 2020 PDUFA after bringing on new API maker
Source: fierce